Many patients begin to feel increased energy within 2-4 hours of their injection, with peak effects typically occurring within 24-48 hours
What We Don't Know: No human clinical trials yet
At the molecular level, AOD-9604 interacts with beta-3 adrenergic receptors on adipocytes (fat cells), triggering a signaling cascade that increases intracellular cyclic AMP levels
Supports Healthy Cell Function and Healthy Aging
D., Quan, S., Kang, T., & Koch, R
Full AI Image Prompt: Create a clean regulatory infographic titled GHK-Cu Regulatory Context Map. Show a horizontal map with four labeled blocks: Cosmetic context, Non-injectable compounding review, Injectable safety concern, and Approved drug labeling. Include a small callout that says Product category affects evidence and safety interpretation. Use document-style icons, simple arrows, and a professional clinical design with white background, gray, blue, and copper accents